Human Formulations

Cefuroxime Axetil 125 mg5ml

Cefuroxime Axetil 125 mg5ml is a oral suspension / dry syrup formulated with Cefuroxime Axetil 125 mg5ml. The listed active ingredient profile is Cefuroxime Axetil mg5ml, placing the product in the cephalosporin antibiotic category. The formulation contai

Oral LiquidsDry Syrup Single Ingredient Oral Suspension / Dry Syrup
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Oral Liquids, Dry Syrup
Dosage Form
Oral Suspension / Dry Syrup
Product Type
Single Ingredient

Available strengths

Cefuroxime Axetil 125 mg5ml

Description

Cefuroxime Axetil 125 mg5ml is a oral suspension / dry syrup formulated with Cefuroxime Axetil 125 mg5ml. The listed active ingredient profile is Cefuroxime Axetil mg5ml, placing the product in the cephalosporin antibiotic category. The formulation contains a cephalosporin antibacterial that acts against susceptible bacteria by interfering with bacterial cell-wall synthesis. The liquid presentation is supplied as an oral suspension/dry-syrup product; reconstitution, shaking, storage and discard instructions must follow the approved label. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured